Corvus Pharmaceuticals, Inc.

NORTHERN TRUST CORP CRVS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

429,771

Value ($000)

3,309

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	3,309	0.0%	429,771	12/31/2025
2025 Q3	11/14/2025	3,438	0.0%	466,486	9/30/2025
2025 Q2	8/13/2025	1,613	0.0%	403,149	6/30/2025
2025 Q1	5/13/2025	348	0.0%	109,296	3/31/2025
2024 Q4	2/14/2025	567	0.0%	106,013	12/31/2024
2024 Q3	11/13/2024	557	0.0%	105,450	9/30/2024
2024 Q2	8/14/2024	151	0.0%	82,990	6/30/2024
2024 Q1	5/14/2024	116	0.0%	64,949	3/31/2024
2023 Q4	2/13/2024	114	0.0%	65,017	12/31/2023
2023 Q3	11/13/2023	95	0.0%	65,017	9/30/2023
2023 Q2	8/11/2023	149	0.0%	65,017	6/30/2023
2023 Q1	5/15/2023	56	0.0%	61,668	3/31/2023
2022 Q4	2/13/2023	52	0.0%	61,668	12/31/2022
2022 Q3	11/14/2022	43	0.0%	52,226	9/30/2022
2022 Q2	8/12/2022	52	0.0%	52,226	6/30/2022
2022 Q1	5/13/2022	86	0.0%	52,226	3/31/2022
2021 Q4	2/8/2022	126	0.0%	52,226	12/31/2021
2021 Q3	11/15/2021	287	0.0%	59,262	9/30/2021
2021 Q2	8/13/2021	158	0.0%	59,262	6/30/2021
2021 Q1	5/12/2021	116	0.0%	37,878	3/31/2021
2020 Q4	2/11/2021	105	0.0%	29,445	12/31/2020
2020 Q3	11/16/2020	118	0.0%	29,445	9/30/2020
2020 Q2	8/14/2020	73	0.0%	26,910	6/30/2020
2020 Q1	5/14/2020	57	0.0%	26,910	3/31/2020
2019 Q4	2/14/2020	146	0.0%	26,910	12/31/2019